TalkMed Group Statistics

Total Valuation

TalkMed Group has a market cap or net worth of SGD 577.53 million. The enterprise value is 492.82 million.

Market Cap	577.53M
Enterprise Value	492.82M

Important Dates

The next estimated earnings date is Wednesday, February 19, 2025.

Earnings Date	Feb 19, 2025
Ex-Dividend Date	Aug 14, 2024

Share Statistics

TalkMed Group has 1.33 billion shares outstanding. The number of shares has increased by 0.35% in one year.

Current Share Class	n/a
Shares Outstanding	1.33B
Shares Change (YoY)	+0.35%
Shares Change (QoQ)	+0.50%
Owned by Insiders (%)	85.52%
Owned by Institutions (%)	n/a
Float	192.26M

Valuation Ratios

The trailing PE ratio is 20.93.

PE Ratio	20.93
Forward PE	n/a
PS Ratio	7.29
PB Ratio	6.96
P/TBV Ratio	6.96
P/FCF Ratio	17.14
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.26, with an EV/FCF ratio of 14.62.

EV / Earnings	17.42
EV / Sales	6.23
EV / EBITDA	14.26
EV / EBIT	15.52
EV / FCF	14.62

Financial Position

The company has a current ratio of 3.85, with a Debt / Equity ratio of 0.11.

Current Ratio	3.85
Quick Ratio	3.79
Debt / Equity	0.11
Debt / EBITDA	0.23
Debt / FCF	0.24
Interest Coverage	143.11

Financial Efficiency

Return on equity (ROE) is 33.27% and return on invested capital (ROIC) is 24.30%.

Return on Equity (ROE)	33.27%
Return on Assets (ROA)	19.54%
Return on Capital (ROIC)	24.30%
Revenue Per Employee	341,017
Profits Per Employee	121,966
Employee Count	232
Asset Turnover	0.75
Inventory Turnover	28.23

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +14.47% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+14.47%
50-Day Moving Average	0.45
200-Day Moving Average	0.41
Relative Strength Index (RSI)	39.25
Average Volume (20 Days)	14,845

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TalkMed Group had revenue of SGD 79.12 million and earned 28.30 million in profits. Earnings per share was 0.02.

Revenue	79.12M
Gross Profit	44.04M
Operating Income	32.77M
Pretax Income	32.45M
Net Income	28.30M
EBITDA	33.41M
EBIT	32.77M
Earnings Per Share (EPS)	0.02

Full Income Statement

Balance Sheet

The company has 85.67 million in cash and 8.19 million in debt, giving a net cash position of 77.48 million or 0.06 per share.

Cash & Cash Equivalents	85.67M
Total Debt	8.19M
Net Cash	77.48M
Net Cash Per Share	0.06
Equity (Book Value)	75.75M
Book Value Per Share	0.06
Working Capital	68.65M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 34.32 million and capital expenditures -617,000, giving a free cash flow of 33.70 million.

Operating Cash Flow	34.32M
Capital Expenditures	-617,000
Free Cash Flow	33.70M
FCF Per Share	0.03

Full Cash Flow Statement

Margins

Gross margin is 55.67%, with operating and profit margins of 41.42% and 35.77%.

Gross Margin	55.67%
Operating Margin	41.42%
Pretax Margin	41.02%
Profit Margin	35.77%
EBITDA Margin	42.23%
EBIT Margin	41.42%
FCF Margin	42.60%

Dividends & Yields

This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 5.06%.

Dividend Per Share	0.02
Dividend Yield	5.06%
Dividend Growth (YoY)	50.00%
Years of Dividend Growth	n/a
Payout Ratio	103.08%
Buyback Yield	-0.35%
Shareholder Yield	4.71%
Earnings Yield	4.78%
FCF Yield	5.84%

Dividend Details

Stock Splits

The last stock split was on April 28, 2017. It was a forward split with a ratio of 2.

Last Split Date	Apr 28, 2017
Split Type	Forward
Split Ratio	2

Scores

TalkMed Group has an Altman Z-Score of 14.41.

Altman Z-Score	14.41
Piotroski F-Score	n/a